The company said it regularly invests 6 to 7 percent of its annual sales revenues in R&D. It has worldwide R&D facilities in the Chinese mainland, Europe, Japan, Singapore, and the United States.
The company said today that?it has begun to roll out a new HTML5 web player for Amazon Video in the U.S., UK, Germany, Austria and Japan for Chrome, Internet Explorer on Windows 8.1, and Microsoft’s new Edge browser on Windows 10. The company says the web player will bring?improved performance compared to Silverlight or?Flash, with an interface that’s designed to look similar to the company’s Fire TV video player.
The company said the?money will be used?to?help deliver an?open cloud platform for content, community and commerce.
The company's 2017 financial results showed that Hangzhou Robam Appliances achieved a year-on-year growth of 20.78 percent, with operating revenue of 7 billion yuan.
The company unveiled its unaudited financial report for the second quarter of 2019 last week. 58.com posted 4.1 billion yuan in revenue for the quarter ended in June, up 20 percent year-on-year and beating previous forecasts. Its gross profit hit 3.7 billion yuan, also up about 19.8 percent year-on-year. Its gross profit margin stood at 89.5 percent.
The company’s updated?roadmap follows a number of bold moves that the Minneapolis-based retailer has made recently against its competitors, including Amazon and?Walmart. For instance, last week Target reduced its minimum online order requirement to to qualify for free shipping of online purchases after experimenting this holiday with lifting?all requirements to receive?free shipping.
提高seo排名
The company's annual active customer accounts increased to 321.3 million in the twelve months ending in June 30, up from 310.5 million in the twelve months ending in March 31.
The company will retain a majority shareholding in Sinopec Marketing upon completion of the overseas listing.
The company then brought the board to court in 2016 and appealed in 2017, but both verdicts in the first hearing and appeal hearing ruled in favor of the board. Sun Mingjuan, the board's lawyer, argued that the bottle should be regarded as a common container for liquors, and it has "no obvious specificity".
The company's self-developed cancer drug, known as Brukinsa (zanubrutinib) in capsule form, was granted market access by the National Medical Products Administration in June this year.